AG˹ٷ

STOCK TITAN

[Form 4] Incyte Genomics Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Insider transaction overview: Cencora, Inc. (NYSE: COR) filed a Form 4 showing that Executive Vice President Elizabeth S. Campbell acquired company stock on 06/30/2025.

  • Shares acquired: 45.611 common shares.
  • Purchase price: $254.873 per share.
  • Total outlay: � $11.6 thousand.
  • Post-transaction ownership: 14,710.141 shares held directly.
  • Transaction type: Purchase through the Employee Stock Purchase Plan, exempt under Rule 16b-3(c).

No derivative securities were involved and no additional material events or financial data were disclosed. The purchase represents a routine, small-scale increase (�0.3 % of the executive’s existing holding) and is unlikely to have a material impact on Cencora’s valuation, but it does modestly reinforce insider alignment with shareholders.

Panoramica sulla transazione interna: Cencora, Inc. (NYSE: COR) ha presentato un Modulo 4 che mostra che la Vicepresidente Esecutiva Elizabeth S. Campbell ha acquistato azioni della società il 30/06/2025.

  • Azioni acquistate: 45.611 azioni ordinarie.
  • Prezzo di acquisto: 254,873 $ per azione.
  • Spesa totale: circa 11,6 mila $.
  • Proprietà dopo la transazione: 14.710,141 azioni detenute direttamente.
  • Tipo di transazione: Acquisto tramite il Piano di Acquisto Azionario per Dipendenti, esente ai sensi della Regola 16b-3(c).

Non sono stati coinvolti titoli derivati né sono stati divulgati ulteriori eventi materiali o dati finanziari. L’acquisto rappresenta un aumento di routine e di piccola entità (circa lo 0,3% della partecipazione esistente dell’esecutivo) e probabilmente non avrà un impatto significativo sulla valutazione di Cencora, ma rafforza modestamente l’allineamento degli insider con gli azionisti.

Resumen de la transacción interna: Cencora, Inc. (NYSE: COR) presentó un Formulario 4 que muestra que la Vicepresidenta Ejecutiva Elizabeth S. Campbell adquirió acciones de la compañía el 30/06/2025.

  • Acciones adquiridas: 45.611 acciones comunes.
  • Precio de compra: 254,873 $ por acción.
  • Gasto total: aproximadamente 11.6 mil $.
  • Propiedad tras la transacción: 14,710.141 acciones en propiedad directa.
  • Tipo de transacción: Compra a través del Plan de Compra de Acciones para Empleados, exenta bajo la Regla 16b-3(c).

No se involucraron valores derivados ni se divulgaron eventos materiales adicionales o datos financieros. La compra representa un aumento rutinario y de pequeña escala (�0.3 % de la participación existente del ejecutivo) y probablemente no tendrá un impacto material en la valoración de Cencora, pero refuerza modestamente la alineación de los internos con los accionistas.

내부� 거래 개요: Cencora, Inc. (NYSE: COR)은 부사장 Elizabeth S. Campbell� 2025� 6� 30� 회사 주식� 취득했음� 보여주는 Form 4� 제출했습니다.

  • 취득 주식 �: 보통� 45,611�.
  • 매입 가�: 주당 $254.873.
  • � 지출액: � $11,600.
  • 거래 � 보유 주식: 직접 보유 14,710.141�.
  • 거래 유형: 직원 주식 구매 계획� 통한 매입, Rule 16b-3(c)� 따른 면제 거래.

파생 증권은 포함되지 않았으며 추가적인 중요 사건이나 재무 데이터는 공개되지 않았습니�. 이번 매입은 기존 보유 주식� � 0.3%� 해당하는 일상적이� 소규모의 증가�, Cencora� 기업 가치에 중대� 영향� 미치지� 않으� 내부자와 주주 간의 이해관� 일치� 다소 강화합니�.

Vue d'ensemble de la transaction d'initié : Cencora, Inc. (NYSE : COR) a déposé un formulaire 4 indiquant que la vice-présidente exécutive Elizabeth S. Campbell a acquis des actions de la société le 30/06/2025.

  • Actions acquises : 45 611 actions ordinaires.
  • Prix d'achat : 254,873 $ par action.
  • Dépense totale : environ 11,6 milliers de dollars.
  • Possession après la transaction : 14 710,141 actions détenues directement.
  • Type de transaction : Achat via le Plan d'achat d'actions des employés, exempté en vertu de la règle 16b-3(c).

Aucun titre dérivé n'a été impliqué et aucun événement matériel ou donnée financière supplémentaire n'a été divulgué. L'achat représente une augmentation de routine et de petite ampleur (environ 0,3 % de la détention existante de la dirigeante) et aura probablement peu d'impact sur la valorisation de Cencora, mais renforce modestement l'alignement des initiés avec les actionnaires.

Übersicht der Insider-Transaktion: Cencora, Inc. (NYSE: COR) reichte ein Formular 4 ein, das zeigt, dass die Executive Vice President Elizabeth S. Campbell am 30.06.2025 Unternehmensaktien erworben hat.

  • Erworbene Aktien: 45.611 Stammaktien.
  • Kaufpreis: 254,873 $ pro Aktie.
  • Gesamtausgabe: ca. 11,6 Tausend $.
  • Besitz nach der Transaktion: 14.710,141 direkt gehaltene Aktien.
  • Transaktionstyp: Kauf über den Employee Stock Purchase Plan, ausgenommen gemäß Regel 16b-3(c).

Es wurden keine Derivate einbezogen und keine weiteren wesentlichen Ereignisse oder Finanzdaten offengelegt. Der Kauf stellt eine routinemäßige, geringfügige Erhöhung (ca. 0,3 % des bestehenden Bestands der Führungskraft) dar und wird wahrscheinlich keinen wesentlichen Einfluss auf die Bewertung von Cencora haben, stärkt jedoch moderat die Übereinstimmung der Insider mit den Aktionären.

Positive
  • Executive VP’s direct ownership increased by 45.611 shares, aligning management and shareholder interests.
Negative
  • The purchase size is financially immaterial to both the insider’s position and the company’s overall float, limiting its signaling power.

Insights

TL;DR Minor ESPP purchase by EVP; positive signal but financially immaterial.

The Form 4 reveals that EVP Elizabeth S. Campbell bought 45.611 shares at $254.873 each through Cencora’s ESPP. While insiders buying shares generally suggests confidence, the $11.6 k purchase is negligible relative to Cencora’s market cap and the executive’s 14.7 k-share stake. Because the shares were obtained via a standing purchase plan rather than an opportunistic open-market trade, the informational value is limited. I classify the filing as neutral: noteworthy for tracking insider activity but not sufficiently large to influence valuation or liquidity.

Panoramica sulla transazione interna: Cencora, Inc. (NYSE: COR) ha presentato un Modulo 4 che mostra che la Vicepresidente Esecutiva Elizabeth S. Campbell ha acquistato azioni della società il 30/06/2025.

  • Azioni acquistate: 45.611 azioni ordinarie.
  • Prezzo di acquisto: 254,873 $ per azione.
  • Spesa totale: circa 11,6 mila $.
  • Proprietà dopo la transazione: 14.710,141 azioni detenute direttamente.
  • Tipo di transazione: Acquisto tramite il Piano di Acquisto Azionario per Dipendenti, esente ai sensi della Regola 16b-3(c).

Non sono stati coinvolti titoli derivati né sono stati divulgati ulteriori eventi materiali o dati finanziari. L’acquisto rappresenta un aumento di routine e di piccola entità (circa lo 0,3% della partecipazione esistente dell’esecutivo) e probabilmente non avrà un impatto significativo sulla valutazione di Cencora, ma rafforza modestamente l’allineamento degli insider con gli azionisti.

Resumen de la transacción interna: Cencora, Inc. (NYSE: COR) presentó un Formulario 4 que muestra que la Vicepresidenta Ejecutiva Elizabeth S. Campbell adquirió acciones de la compañía el 30/06/2025.

  • Acciones adquiridas: 45.611 acciones comunes.
  • Precio de compra: 254,873 $ por acción.
  • Gasto total: aproximadamente 11.6 mil $.
  • Propiedad tras la transacción: 14,710.141 acciones en propiedad directa.
  • Tipo de transacción: Compra a través del Plan de Compra de Acciones para Empleados, exenta bajo la Regla 16b-3(c).

No se involucraron valores derivados ni se divulgaron eventos materiales adicionales o datos financieros. La compra representa un aumento rutinario y de pequeña escala (�0.3 % de la participación existente del ejecutivo) y probablemente no tendrá un impacto material en la valoración de Cencora, pero refuerza modestamente la alineación de los internos con los accionistas.

내부� 거래 개요: Cencora, Inc. (NYSE: COR)은 부사장 Elizabeth S. Campbell� 2025� 6� 30� 회사 주식� 취득했음� 보여주는 Form 4� 제출했습니다.

  • 취득 주식 �: 보통� 45,611�.
  • 매입 가�: 주당 $254.873.
  • � 지출액: � $11,600.
  • 거래 � 보유 주식: 직접 보유 14,710.141�.
  • 거래 유형: 직원 주식 구매 계획� 통한 매입, Rule 16b-3(c)� 따른 면제 거래.

파생 증권은 포함되지 않았으며 추가적인 중요 사건이나 재무 데이터는 공개되지 않았습니�. 이번 매입은 기존 보유 주식� � 0.3%� 해당하는 일상적이� 소규모의 증가�, Cencora� 기업 가치에 중대� 영향� 미치지� 않으� 내부자와 주주 간의 이해관� 일치� 다소 강화합니�.

Vue d'ensemble de la transaction d'initié : Cencora, Inc. (NYSE : COR) a déposé un formulaire 4 indiquant que la vice-présidente exécutive Elizabeth S. Campbell a acquis des actions de la société le 30/06/2025.

  • Actions acquises : 45 611 actions ordinaires.
  • Prix d'achat : 254,873 $ par action.
  • Dépense totale : environ 11,6 milliers de dollars.
  • Possession après la transaction : 14 710,141 actions détenues directement.
  • Type de transaction : Achat via le Plan d'achat d'actions des employés, exempté en vertu de la règle 16b-3(c).

Aucun titre dérivé n'a été impliqué et aucun événement matériel ou donnée financière supplémentaire n'a été divulgué. L'achat représente une augmentation de routine et de petite ampleur (environ 0,3 % de la détention existante de la dirigeante) et aura probablement peu d'impact sur la valorisation de Cencora, mais renforce modestement l'alignement des initiés avec les actionnaires.

Übersicht der Insider-Transaktion: Cencora, Inc. (NYSE: COR) reichte ein Formular 4 ein, das zeigt, dass die Executive Vice President Elizabeth S. Campbell am 30.06.2025 Unternehmensaktien erworben hat.

  • Erworbene Aktien: 45.611 Stammaktien.
  • Kaufpreis: 254,873 $ pro Aktie.
  • Gesamtausgabe: ca. 11,6 Tausend $.
  • Besitz nach der Transaktion: 14.710,141 direkt gehaltene Aktien.
  • Transaktionstyp: Kauf über den Employee Stock Purchase Plan, ausgenommen gemäß Regel 16b-3(c).

Es wurden keine Derivate einbezogen und keine weiteren wesentlichen Ereignisse oder Finanzdaten offengelegt. Der Kauf stellt eine routinemäßige, geringfügige Erhöhung (ca. 0,3 % des bestehenden Bestands der Führungskraft) dar und wird wahrscheinlich keinen wesentlichen Einfluss auf die Bewertung von Cencora haben, stärkt jedoch moderat die Übereinstimmung der Insider mit den Aktionären.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Denton Sheila A.

(Last) (First) (Middle)
1801 AUGUSTINE CUT-OFF

(Street)
WILMINGTON DE 19803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 M 599 A $58.06 27,103 D
Common Stock 07/02/2025 S 599 D $68.61 26,504(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $58.06 07/02/2025 M 599 (2) 10/02/2033 Common Stock 599 $0 16,158 D
Explanation of Responses:
1. This includes an aggregate of 25,848 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
2. Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.
Remarks:
/s/ Elizabeth Feeney, Attorney-In-Fact 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Cencora (COR) shares did EVP Elizabeth S. Campbell buy?

She acquired 45.611 common shares on 06/30/2025.

What price was paid for the Cencora shares?

The shares were purchased at $254.873 per share.

How many COR shares does the EVP own after this transaction?

Post-transaction, Campbell beneficially owns 14,710.141 shares directly.

Was the insider purchase an open-market transaction?

No. The shares were bought through the Employee Stock Purchase Plan and are exempt under Rule 16b-3(c).

Does this Form 4 indicate major insider buying at Cencora?

No. The transaction is modest in size and appears to be a routine ESPP purchase rather than a significant open-market buy.
Incyte Corp

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Latest SEC Filings

INCY Stock Data

13.20B
189.32M
1.99%
96.76%
3.02%
Biotechnology
Services-commercial Physical & Biological Research
United States
WILMINGTON